In today's Daily Digest, we'll review:

1. Any new position added today
2. Adjustment made to an existing position (if any)
3. Any exits since last report
4. Current status of open campaigns.

Let's dig in!

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Baker Bros Advisors LLC.

The hedge fund revealed a purchase of Madrigal Pharmaceuticals, Inc $MDGL worth $23 million.

These are the registration details for our LIVE Mid-month Conference Call for Premium Members of All Star Charts.

Our Live Call will be held on Monday November 20th @ 6PM ET. As always, if you cannot make the call live, the video and slides will be archived and published here along with every other live call since 2015.

Here are the details for Monday night:

This is a raging Bull Market in stocks.

Seasonal strength is kicking in, right in time.

We'll be discussing this all on Monday night @ 6PM ET during our LIVE Conference Call. Premium Members can Register Here.

Sector rotation is the lifeblood of a bull market. This cycle is clearly no different.

And breadth expansion reigns. Remember all these angry people telling you how Small-caps were going to drag the rest of the market lower?

It's actually been the exact opposite.

All of this is perfectly normal. Take the time to go back and see for yourself.

From the Desk of Ian Culley @IanCulley

The dollar has gone from slinging cheese to lobbing cookies.

Sellers finally got ahold of the US Dollar Index $DXY on Tuesday, sending it on its steepest single-day decline since October 2022.

Recall what followed for the dollar…

The DXY formed a major top and fell victim to not one but two subsequent 1 percent-plus daily drawdowns. 

Check out the DXY chart with the one-day rate-of-change in the upper pane:

The DXY dropped almost 1.5% during Tuesday's session. That’s a huge move for a currency (with the exception of the Turkish lira and perhaps the Polish zloty).

Based on the action witnessed last fall, it wouldn’t be surprising for the DXY to experience a reprieve from selling pressure in the coming days, followed by renewed downside action. 

As I mentioned last week, “If and when it (the DXY) falls below...

This is the video recording of the November 15, 2023, Hot Corner Insider Weekly Strategy Session.

Today, a "darling" company in the media thanks to new obesity drugs and other good news hitting the media airwaves is selling off. In fact, its having its worst day relative to its sector peers in many years.

Someone forgot to tell Eli Lilly $LLY that a new bull market run may recently have gotten under way. Of course, it was already way ahead of the game. In fact, look at this long-term chart:

These aren't usually the trends I like to take the other side of.

But perhaps it's gone on a little too long and it's ready to pause and retrace?

This stock could get cut in half and the long-term trend would still be intact.

When we zoom in a little closer, we see a very notable (and sizeable) gap from this summer where the stock jumped from $450 per share to north of $500 per share overnight:

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Baker Bros Advisors LLC.

The hedge fund revealed a purchase of Madrigal Pharmaceuticals, Inc $MDGL worth $23 million.

In today's Daily Digest, we'll review:

1. Any new position added today
2. Adjustment made to an existing position (if any)
3. Any exits since last report
4. Current status of open campaigns.

Let's dig in!

From the Desk of Steve Strazza and Alfonso Depablos

Today’s most significant insider transaction comes in a Form 4 filing by Decheng Capital Management, a hedge fund focused on investing in early-stage life science companies.

Decheng reported a purchase in the biotech company Alpine Immune Sciences $ALPN worth more than $4.6 million.

This is the best time of the year for stocks.

And stocks are doing very well.

In other words, perfectly normal market behavior.

In fact, this is exactly when Small-caps historically start to outperform their large-cap counterparts.

And sure enough, that's exactly what we're seeing.

Here's a great chart from Jeff Hirsch and Jay Kaeppel showing these seasonal tendencies:

From the Desk of Ian Culley @IanCulley

Miami is pure gold.

It sways to its own beat, enticing and intoxicating even the insular traveler.

Incidentally, I was engulfed by the city’s rhythm as I attended a family wedding last weekend.

And it was wild!

I danced with family and friends and sipped bubbles at sunset in Key Biscayne straight through to the early morning hours along South Beach.

But this old dog would never have made it to dawn without my wife’s crazy cousins. 

They displayed an appetite for reckless abandon that gold longs to witness from its own crazy cousin…

From the Desk of Steve Strazza and Alfonso Depablos

Today’s most significant insider transaction comes in a Form 4 filing by Decheng Capital Management, a hedge fund focused on investing in early-stage life science companies.

Decheng reported a purchase in the biotech company Alpine Immune Sciences $ALPN worth more than $4.6 million.

In today's Daily Digest, we'll review:

1. Any new position added today
2. Adjustment made to an existing position (if any)
3. Any exits since last report
4. Current status of open campaigns.

Let's dig in!

From the Desk of Ian Culley @IanCulley

Miami is pure gold.

It sways to its own beat, enticing and intoxicating even the insular traveler.

Incidentally, I was engulfed by the city’s rhythm as I attended a family wedding last weekend.

And it was wild!

I danced with family and friends and sipped bubbles at sunset in Key Biscayne straight through to the early morning hours along South Beach.

But this old dog would never have made it to dawn without my wife’s crazy cousins. 

They displayed an appetite for reckless abandon that gold longs to witness from its own crazy cousin…

Silver!

Gold wants to party like a rock star until the wee hours as it twists and turns toward a new all-time high.

Unfortunately, silver doesn’t want to dance.

Check out gold futures overlaid with the silver-to-gold ratio:

The silver-to-gold ratio can’t find its feet. Instead, it remains glued to a shelf of former lows.

Silver needs to make its way to the dance floor if gold has any chance of reaching a new high. But silver must not only participate, it must take the lead.

Money flows to the riskier areas of...

From the Desk of Steve Strazza and Alfonso Depablos

Today’s most significant insider transaction comes in a Form 4 filing by Block $SQ director Roelof Botha.

Botha reported a $27 million purchase of SQ shares.

From the desk of Steve Strazza @Sstrazza.

Welcome back to Under the Hood, where we'll cover all the action for the week ended November 11, 2023. This report is published bi-weekly and rotated with The Minor Leaguers.

What we do here is analyze the most popular stocks during the week and find opportunities to either join in and ride these momentum names higher, or fade the crowd and bet against them.

We use a variety of sources to generate the list of most popular names.

There are so many new data sources available that all we need to do is organize and curate them in a way that shows us exactly what we want: a list of stocks seeing an unusual increase in investor interest.

Click here for a behind-the-scenes look at our process.

Whether we’re measuring increasing interest based on large institutional purchases, unusual options activity, or simply...

From the Desk of Steve Strazza @sstrazza and Alfonso Depablos @Alfcharts

This is one of our favorite bottom-up scans: Follow the Flow.

In this note, we simply create a universe of stocks that experienced the most unusual options activity — either bullish or bearish, but not both.

We utilize options experts, both internally and through our partnership with The TradeXchange. Then, we dig through the level 2 details and do all the work upfront for our clients.

Our goal is to isolate only those options market splashes that represent levered and high-conviction, directional bets.

We also weed out hedging activity and ensure there are no offsetting trades that either neutralize or cap the risk on these unusual options trades.

What remains is a list of stocks that large financial institutions are putting big money behind.

And they’re doing so for one reason only: because they think...